Ghosts still present in the medical machine

Jones, Nicola
September 2009
Nature;9/17/2009, Vol. 461 Issue 7262, p325
Academic Journal
The article reports that ghostwriting in medical literature remains, despite the policy changes in drug-company and efforts of journals to cut down the practice in the U.S. It states that the ghostwriting, is a practice that involves pharmaceutical companies designing and paying for studies or reviews with a guest author to be credited, while the company goes unacknowledged. Moreover, a survey of 600 authors shows that 7.8% of the respondents are ghost authors.


Related Articles

  • Ghostwriting: The Dirty Little Secret of Medical Publishing That Just Got Bigger.  // PLoS Clinical Trials;Sep2009, Vol. 6 Issue 9, Special section p1 

    The article focuses on the issue of ghostwriting in medical publishing. It claims that drug companies and medical education and communication companies have built a profitable ghostwriting industry because of the failure of editors, medical schools and universities to address the issue. It cites...

  • Ghost and host in the Little House books. Holtz, William // Studies in the Literary Imagination;Fall96, Vol. 29 Issue 2, p41 

    Examines the function and responsibility of a ghost writer. Work collaboration between an author and an editor; Definition of ghost writer; Collaborative writing in the book `The Ghost in the Little House'; Granting of the ghost its own measure of the creative function; Significance of the title...

  • Jets for laughs... Masin, Herman L. // Coach & Athletic Director;Nov97, Vol. 67 Issue 4, p10 

    Presents information on the role ghostwriters play in the lives of famous athletes. Reference to football player Keyshawn Johnson; How he used his ghostwriter.

  • Medical publication ghostwriting report gets mixed review.  // Infectious Diseases in Children;Sep2010, Vol. 23 Issue 9, p45 

    The article discloses the findings of a report on medical ghostwriting released by the office of U.S. Senator Charles Grassley on June 24, 2010 in which the National Institutes of Health (NIH), institutions and medical journals play a critical role in ensuring an adequate and meaningful disclosure.

  • Ghostwriting Revisited: New Perspectives but Few Solutions in Sight. V. B.; E. V.; J. C.; S. J.; M. N.; P. S. // PLoS Medicine;Aug2011, Vol. 8 Issue 8, p1 

    An introduction is presented in which the authors discuss various reports within the issue on topics including ghostwriting of medical journals and the authorship of medical literature.

  • Get paid in advance—and other tips from a successful ghostwriter: The author has worked with Hollywood celebrities, mafia captains and many other colorful characters. Woodcox, Robert Bruce // Writer (Kalmbach Publishing Co.);Dec2011, Vol. 124 Issue 12, p43 

    A personal narrative is presented wherein the author discusses his experiences as a ghostwriter and aspects of his professional development such as getting paid in advance, investigating the entire story of clients before beginning a project, and finding a publisher. INSET: Tips for New...

  • Games Experts Play. Dilenschneider, David V. // Expert Witnesses Annual;Winter2013, Vol. 8 Issue 1, p1 

    The article focuses on the prevalence of ghostwriting in the U.S. as of 2013. It states that the practice of ghostwriting is being used by drug manufacturers in litigation to support arguments concerning the efficacy and safety of their drugs. It reports that "Milwaukee Journal Sentinel"...

  • Ghost Blusters. Pitts, Peter // Pharmaceutical Executive;Feb2006, Vol. 26 Issue 2, p44 

    The article comments on the media's most recent attempt to mar anything supported, promoted, or approved by the pharmaceutical industry by attacking articles in medical journals, ghostwritten by professional medical writers paid by pharmaceutical companies in the United States. According to the...

  • PR View. Herskovits, Beth // Medical Marketing & Media;Feb2006, Vol. 41 Issue 2, p30 

    The article comments on the use of ghostwriters, writers who skewed or omitted potentially damaging research data, in medical journals in the U.S. Critics of the drug industry argue that researchers should recognize that positive research results are more likely to yield continued funding for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics